Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Research and development: 16.7M
Today's EPS Names:
NRIX, VFS, GLDG, More
Financial Fact:
Research and development: 16.7M
Today's EPS Names:
NRIX, VFS, GLDG, More
Join SI Premium – FREE
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Downgrades UWM Holdings Corp. (UWMC) to Neutral
- DHT Holdings reports Q3 2026 TCE earnings of $141,300 per day
- Pepsico (PEP) PT Lowered to $138 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
